MARKET

KYKOF

KYKOF

Kyowa Hakko Kogy
OTCPK
15.55
-0.25
-1.58%
Closed 11:19 09/11 EDT
OPEN
15.55
PREV CLOSE
15.80
HIGH
15.55
LOW
15.55
VOLUME
50
TURNOVER
778
52 WEEK HIGH
26.68
52 WEEK LOW
14.20
MARKET CAP
8.14B
P/E (TTM)
16.14
1D
5D
1M
3M
1Y
5Y
1D
Kyowa Kirin downgraded to Hold from Buy at Jefferies
TipRanks · 3d ago
Kyowa Kirin’s New Blood Cancer Trial: What KK2430 Could Mean for KYKOF Investors
TipRanks · 08/07 16:30
Kyowa Kirin Non-GAAP EPS of ¥103.26, revenue of ¥263.63B; reaffirms FY 2026 outlook
Seeking Alpha · 08/03 07:55
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
Seeking Alpha · 06/29 21:50
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Vertex Pharmaceuticals (VRTX) and Kyowa Kirin Co (OtherKYKOF)
TipRanks · 06/16 12:21
Kura, Kyowa Kirin to present updated frontline data from Phase 1 KOMET-007 trial
TipRanks · 05/12 19:13
Kyowa Kirin reports Q1 results
Seeking Alpha · 05/07 09:43
Kyowa Kirin downgraded to Sell from Buy at Citi
TipRanks · 03/09 09:35
More
About KYKOF
Kyowa Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of medical drugs. The Company operates in Pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The Company operates in Japan and overseas.

Webull offers Kyowa Kirin Co Ltd stock information, including OTCPK: KYKOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KYKOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KYKOF stock methods without spending real money on the virtual paper trading platform.